Business Description
Bioasis Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA09064N1033
Compare
Compare
Traded in other countries / regions
107.GermanyBIOAF.USABTI.Canada IPO Date
2007-07-24Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 41.35 | |||||
| 14-Day RSI | 45.08 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -720.07 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioasis Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.269 | ||
| EPS (TTM) (C$) | -0.033 | ||
| Beta | 0.22 | ||
| Volatility % | 127.92 | ||
| 14-Day RSI | 45.08 | ||
| 14-Day ATR (C$) | 0.000023 | ||
| 20-Day SMA (C$) | 0.005 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (C$) | 0.005 - 0.02 | ||
| Shares Outstanding (Mil) | 79.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioasis Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioasis Technologies Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioasis Technologies Inc Frequently Asked Questions
What is Bioasis Technologies Inc(TSXV:BTI)'s stock price today?
The current price of TSXV:BTI is C$0.01. The 52 week high of TSXV:BTI is C$0.02 and 52 week low is C$0.01.
When is next earnings date of Bioasis Technologies Inc(TSXV:BTI)?
The next earnings date of Bioasis Technologies Inc(TSXV:BTI) is .
Does Bioasis Technologies Inc(TSXV:BTI) pay dividends? If so, how much?
Bioasis Technologies Inc(TSXV:BTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers